Global Anti-infective Agents Market: Overview
Anti-infective agents comprise
antifungals, antibiotics, and antibacterials. They are used to inhibit
the spread of an infectious agent by killing or suppressing it. The
anti-bacterial sector is anticipated to hold the highest share in the
market owing to high prescription of these drugs. The global
anti-infective agents market is expected to grow at a promising pace
during the forecast period due to rising incidences of infectious
diseases across the globe.
Some of the recent developments that may support the growth of the global anti-infective agents market are:
- The Global Antibiotic Research and Development Partnership (“GARDP”) has joined hands with Evotec to tackle the lurking threat of antimicrobial resistance. They are aiming at developing antibiotic treatments for severe diseases by establishing a platform that spans the length of drug development.
- Pfizer launched an antibiotic called Zavicefta for the treatment of gram-negative bacterial infections. The development of Zavicefta stemmed from the need for efficient antibiotics for hard-to-treat diseases. It has now been launched in more than 14 countries.
- Spero Therapeutics has announced a new oral, broad-spectrum compound SPR720 for the treatment non-tuberculous mycobacterial (NTM) disease. NTM is a rare infectious disease which can be easily contracted as the bacteria is easily present in the environment. The entry of SPR720 for treatment of this chronic disease will surely favor the growth of the global anti-infective agents market.
Global Anti-infective Agents Market: Key Growth Dynamics
Recently, there has been an increase in
research and development activities relating to the development of new
anti-infectives with greater potential and efficacy. This has impacted
the global anti-infective agents market favorably, thus propelling its
growth. Moreover, FDA is supporting the discovery of new drugs in the
form of approvals. This has highly stimulated an expansion of the
market.
Additionally, factors such as
anti-microbial resistance to the existing drugs and the rising
health-consciousness have significantly contributed to the growth of
anti-infective agents market. Increasing occurrences of viral infections
such as hepatitis and HIV have further boosted the market’s growth. In
addition to this, advancements in the healthcare infrastructure and an
increase in funding from the government for the research activities
pertaining to discovery of the drugs have fueled the global
anti-infective agents market.
However, there are a few restraining
factors that may hinder the growth of global anti-infective agents
market. Factors such as stringent regulatory framework pertaining to the
usage of drugs and lack of awareness in underdeveloped regions may
impede the market’s growth. Nonetheless, excellent marketing strategies
of the prominent players in the market and a robust distribution network
shall support the growth of global anti-infective agents market.
Global Anti-infective Agents Market: Regional Outlook
On the geographical frontier, North
America holds the highest share in the global anti-infective agents
market. Its dominance in this region can be attributed to high
penetration of anti-infective drugs and excellent healthcare facilities.
Asia Pacific is expected to grow exponentially during the forecast
period owing to high incidences of infective diseases. India dominates
the anti-infective drugs market in Asia Pacific.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment